041910.KQ EstechPharma Co. Ltd

Healthcare Pharmaceuticals KOSDAQ
6,312 KRW
Close of Oct 30, 2026
4,110 10,200
Market cap
KRW 73.7B
P/E
-
P/B
0.50x
ROE
14.1%
Dividend yield
-
Fundamental score
2.1/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 041910.KQ undervalued?

Graham number

The Graham number of EstechPharma Co. Ltd cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

EstechPharma Co. Ltd fundamental analysis

11 of 22 checks passed

ROE 1/2

Moderate return on equity (14.1%), between 10% and 20%.

ROA 1/1

Return on assets (10.6%) is above the industry median (3.4%).

Profit Consistency 1/2

Profitable for 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 1/1

Last year's EPS growth (56.1%) is above the 5-year average (-13.1% a year).

Earnings Growth vs Industry 1/1

Last year's EPS growth (56.1%) is above the industry median (6.6%).

Revenue Growth 0/2

Revenue shrank 3.6% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 2/2

Low debt to equity (24.7%), 40% or less.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 1/1

Operating cash flow covers 20% of total debt.

Interest Coverage 1/1

EBIT is 999.1x against interest expense, well covered.

PE vs Market 0/1

PE is negative or not available.

PE vs Industry 0/1

PE is negative or not available.

PBV 1/1

Price to book (0.5x) is below the industry median (0.8x).

Graham Number 0/1

Graham number needs positive earnings and book value.

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

EstechPharma Co. Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About EstechPharma Co. Ltd

EstechPharma Co., Ltd. manufactures and sells pharmaceuticals products. It also offers raw materials, such as RBM and PLK. The company was formerly known as Estech Chemical and changed its name to EstechPharma Co., Ltd. in January 2001. EstechPharma Co., Ltd. was founded in 1996 and is headquartered in Hwaseong-si, South Korea.

Full company profile